Federal University of Rio de Janeiro   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rio de Janeiro Brazil (1792)

Organization Overview

First Clinical Trial
2000
NCT02852577
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Alexandre Guedes Torres | Federal University of Rio de Janeiro - UFRJ | Federal University of the State of Rio de Janeiro | Hospital Universitário Clementino Fraga Filho | Instituto de Nutrição Josué de Castro/ UFRJ | Instituto de Puericultura e Pediatria Martagao Gesteira | Instituto de Puericultura e Pediatria Martagao Gesteira / Hospital Pediatrico | Laboratory of pulmonary investigation, Federal University, Rio de Janeiro | Maternidade Escola da Universidade Federal do Rio de Janeiro | Ph. D. student in Nutrition Sciences at the Federal University of Rio de Janeiro, Brazil | Professor of Department of Anesthesiology of Federal University of Rio de Janeiro | Rony Schaffel | UFRJ | Universidade Federal de Rio de Janeiro | Universidade Federal do Rio de Janeiro | Universidade Federal do Rio de Janeiro, Brazil | Universidade Federal do Rio de Janeiro - Campus Macaé

Active Ingredients

Drugs in Phase 4 Trials (18)

anidulafungin (eraxis) (1 trial)

cellulose (1 trial)

ciprofibrate (1 trial)

clonazepam (klonopin) (1 trial)

cyclosporine (sandimmune) (1 trial)

epinephrine (levophed) (1 trial)

icosapent ethyl (vascepa) (2 trials)

interferon alpha-2b (Intron-A) (1 trial)

levosimendan (1 trial)

lopinavir (Kaletra) (1 trial)

magnesium sulfate (Tis-U-Sol) (3 trials)

methimazole (tapazole) (1 trial)

palonosetron (aloxi) (1 trial)

paroxetine (paxil) (1 trial)

ribavirin (virazole) (1 trial)

ritonavir (Norvir) (1 trial)

sodium chloride (4 trials)

somatropin (protropin) (1 trial)

Drugs in Phase 3 Trials (20)

bone marrow derived mesenchymal stem cells (1 trial)

cabergoline (dostinex) (1 trial)

carvedilol (coreg) (1 trial)

cisplatin (platinol) (1 trial)

clobetasol (dermovate) (1 trial)

dactinomycin (cosmegen) (1 trial)

diacerein (1 trial)

etoposide (vepesid) (1 trial)

idursulfase (elaprase) (1 trial)

melissa officinalis (1 trial)

methotrexate (1 trial)

pasireotide (signifor) (1 trial)

phytolacca decandra (1 trial)

propolis (1 trial)

propranolol (inderal) (1 trial)

rosuvastatin (crestor) (1 trial)

simvastatin (zocor) (1 trial)

thalidomide (Thalomid) (1 trial)

urea (2 trials)

xylitol (1 trial)

Drugs in Phase 2 Trials (12)

bacille calmette-guerin (1 trial)

clonidine (catapres) (1 trial)

ethambutol (myambutol) (1 trial)

isoniazid (nydrazid) (1 trial)

lidocaine (xylocaine) (1 trial)

methylprednisolone (medrol) (1 trial)

moxifloxacin (avelox) (1 trial)

nilotinib (tasigna) (1 trial)

nitazoxanide (alinia) (2 trials)

pyrazinamide (Aldinamide) (1 trial)

rifampin (1 trial)

rifapentine (priftin) (1 trial)

Drugs in Phase 1 Trials (2)

allogeneic adipose derived mesenchymal stem cell (2 trials)

autologous cells (1 trial)

Drugs in Other Trials (34)

aged garlic extract (1 trial)

beetroot juice (3 trials)

benzathine penicillin (1 trial)

brazil nut (1 trial)

calcium (1 trial)

caspofungin (cancidas) (1 trial)

cassava (1 trial)

coconut flour (1 trial)

coconut oil (1 trial)

conjugated linoleic acid (1 trial)

cow milk (1 trial)

defatted flaxseed flour (1 trial)

eggplant (1 trial)

fish oil (Omegavan) (3 trials)

glucose (1 trial)

golden flaxseed flour (1 trial)

lactobacillus delbrueckii (1 trial)

linolic acid (1 trial)

linseed oil (1 trial)

metformin (glucophage) (1 trial)

nevulose (1 trial)

oat bran (1 trial)

posaconazole (noxafil) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

pumpkin seeds (1 trial)

red beetroot (1 trial)

refined rice flour (1 trial)

unsaturated fatty acids (1 trial)

vitamin a (1 trial)

vitamin d3 (2 trials)

voriconazole (vfend) (1 trial)

watermelon (1 trial)

whole brown flaxseed flour (1 trial)

ω-6 fatty acids (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Acute Lung Injury (Phase 2)

Adenoma (Phase 3)

Agoraphobia (Phase 4)

Bruxism (Phase 3)

Bundle-Branch Block (Phase 2)

Candidemia (Phase 4)

Coronavirus Infections (Phase 2)

Dental Plaque (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Disease (Phase 4)

Dry Eye Syndromes (Phase 4)

Esophageal and Gastric Varices (Phase 3)

Fatty Liver (Phase 3)

Fibrosis (Phase 3)

Glomerulosclerosis, Focal Segmental (Phase 1)

Graft vs Host Disease (Phase 3)

Hemorrhage (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

HIV Infections (Phase 4)

HIV Seropositivity (Phase 4)

Hypertension (Phase 4)

Hypertension, Portal (Phase 3)

Hypertriglyceridemia (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Kidney Diseases (Phase 1)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Liver Cirrhosis (Phase 3)

Liver Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Injury (Phase 2)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Multiple Myeloma (Phase 3)

Nausea (Phase 4)

Neoplasms, Plasma Cell (Phase 3)

Non-alcoholic Fatty Liver Disease (Phase 3)

Oral Manifestations (Phase 3)

Pain, Postoperative (Phase 2)

Panic Disorder (Phase 4)

Pituitary Diseases (Phase 3)

Pituitary Neoplasms (Phase 3)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Postoperative Nausea and Vomiting (Phase 4)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prolactinoma (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Renal Insufficiency, Chronic (Phase 1)

Respiratory Distress Syndrome (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Sleep Bruxism (Phase 3)

Syndrome (Phase 3)

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 62
  • # of Trial APIs: 86